BioBridgeXAll companies

4D Molecular Therapeutics, Inc.

Biotechnology company · Emeryville, California, United States · Nasdaq: FDMT

4D Molecular Therapeutics, Inc. is a biotechnology company headquartered in Emeryville, California, United States. Its earliest recorded incorporation is in 2015. Its shares trade on Nasdaq under the ticker FDMT. It has reported private securities offerings to the US SEC, most recently $90 million sold in a notice filed in 2018.

Profile compiled from public records. Is this your company? Request a correction or update

4D Molecular Therapeutics at a glance

Typebiotechnology company
HeadquartersEmeryville, California, United States
Earliest incorporation on record2015
Stock listingNasdaq: FDMT
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK1650648

What does 4D Molecular Therapeutics do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $90 million sold (2018).

Frequently asked questions about 4D Molecular Therapeutics

Where is 4D Molecular Therapeutics headquartered?

4D Molecular Therapeutics, Inc. is headquartered in Emeryville, California, United States.

What does 4D Molecular Therapeutics do?

4D Molecular Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is 4D Molecular Therapeutics a public company?

Yes. 4D Molecular Therapeutics, Inc. trades on Nasdaq under the ticker FDMT.

When was 4D Molecular Therapeutics founded?

The earliest incorporation on record for 4D Molecular Therapeutics, Inc. is in 2015, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.